跳转至内容
Merck
CN

Gemfibrozil, stretching arms beyond lipid lowering.

Immunopharmacology and immunotoxicology (2009-08-22)
Avik Roy, Kalipada Pahan
摘要

Gemfibrozil is long known for its ability to reduce the level of triglycerides in the blood circulation and to decrease the risk of hyperlipidemia. However, a number of recent studies reveal that apart from its lipid-lowering effects, gemfibrozil can also regulate many other signaling pathways responsible for inflammation, switching of T-helper cells, cell-to-cell contact, migration, and oxidative stress. In this review, we have made an honest attempt to analyze various biological activities of gemfibrozil and associated mechanisms that may help to consider this drug for different human disorders as primary or adjunct therapy.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
吉非罗齐
Supelco
吉非罗齐, Pharmaceutical Secondary Standard; Certified Reference Material
吉非罗齐, European Pharmacopoeia (EP) Reference Standard
吉非罗齐, European Pharmacopoeia (EP) Reference Standard